[go: up one dir, main page]

RU96101169A - APPLICATION OF ROPIVACAIN IN THE PRODUCTION OF THE PHARMACEUTICAL PRODUCT WITH ANALGESIC ACTION WITH MINIMUM MOTOR BLOCK - Google Patents

APPLICATION OF ROPIVACAIN IN THE PRODUCTION OF THE PHARMACEUTICAL PRODUCT WITH ANALGESIC ACTION WITH MINIMUM MOTOR BLOCK

Info

Publication number
RU96101169A
RU96101169A RU96101169/14A RU96101169A RU96101169A RU 96101169 A RU96101169 A RU 96101169A RU 96101169/14 A RU96101169/14 A RU 96101169/14A RU 96101169 A RU96101169 A RU 96101169A RU 96101169 A RU96101169 A RU 96101169A
Authority
RU
Russia
Prior art keywords
ropivacaine
ropivacain
production
application
pharmaceutical product
Prior art date
Application number
RU96101169/14A
Other languages
Russian (ru)
Other versions
RU2152215C1 (en
Inventor
Торстен Эек Арне
Original Assignee
Астра Актиеболаг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE19939302218A external-priority patent/SE9302218D0/en
Application filed by Астра Актиеболаг filed Critical Астра Актиеболаг
Publication of RU96101169A publication Critical patent/RU96101169A/en
Application granted granted Critical
Publication of RU2152215C1 publication Critical patent/RU2152215C1/en

Links

Claims (6)

1. Применение фармацевтически приемлемой соли ропивакаина при изготовлении фармацевтического препарата с сенсорной блокадой и с минимальной моторной блокадой, при этом концентрация ропивакаина составляет менее 0,5 мас.%.1. The use of a pharmaceutically acceptable salt of ropivacaine in the manufacture of a pharmaceutical preparation with sensory blockade and with minimal motor blockade, wherein the concentration of ropivacaine is less than 0.5 wt.%. 2. Применение по п.1, отличающееся тем, что ропивакаин находится в форме своего гидрохлорида. 2. The use according to claim 1, characterized in that ropivacaine is in the form of its hydrochloride. 3. Применение по п.1, отличающееся тем, что концентрация ропивакаина составляет от 0,1 до 0,45 мас.%. 3. The use according to claim 1, characterized in that the concentration of ropivacaine is from 0.1 to 0.45 wt.%. 4. Применение по п.3, отличающееся тем, что концентрация ропивакаина составляет 0,2 мас.%. 4. The use according to claim 3, characterized in that the concentration of ropivacaine is 0.2 wt.%. 5. Способ лечения человека, нуждающегося в ослаблении боли, с минимальной моторной блокадой путем использования небольшого эффективного количества фармацевтически приемлемой соли ропивакаина. 5. A method of treating a person in need of pain relief with minimal motor blockade by using a small effective amount of a pharmaceutically acceptable salt of ropivacaine. 6. Фармацевтический препарат для применения устранения острой боли с минимальной моторной блокадой, отличающийся тем, что активный ингредиент представляет собой фармацевтически приемлемую соль ропивакаина при концентрации менее 0,5 мас.%. 6. A pharmaceutical preparation for applying acute pain management with minimal motor blockade, characterized in that the active ingredient is a pharmaceutically acceptable salt of ropivacaine at a concentration of less than 0.5 wt.%.
RU96101169/14A 1993-06-28 1994-05-26 Use of ropivacaine in preparing pharmaceutical preparation with analgetic effect and minimal motor blockade RU2152215C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (en) 1993-06-28 1993-06-28 NEW USE
SE9302218-4 1993-06-28

Publications (2)

Publication Number Publication Date
RU96101169A true RU96101169A (en) 1998-03-27
RU2152215C1 RU2152215C1 (en) 2000-07-10

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96101169/14A RU2152215C1 (en) 1993-06-28 1994-05-26 Use of ropivacaine in preparing pharmaceutical preparation with analgetic effect and minimal motor blockade

Country Status (32)

Country Link
US (2) US5670524A (en)
EP (1) EP0706395B1 (en)
JP (1) JP3725541B2 (en)
CN (1) CN1074918C (en)
AT (1) ATE216237T1 (en)
BR (1) BR9406865A (en)
CA (1) CA2165446C (en)
CZ (1) CZ283300B6 (en)
DE (2) DE69430427T2 (en)
DK (1) DK0706395T3 (en)
EE (1) EE03205B1 (en)
ES (1) ES2099048T3 (en)
FI (1) FI956269L (en)
GR (1) GR970300013T1 (en)
HU (1) HU218949B (en)
IL (1) IL110006A (en)
IS (1) IS4174A (en)
LT (1) LT3449B (en)
LV (1) LV12918B (en)
MY (1) MY119360A (en)
NO (1) NO955313L (en)
NZ (1) NZ268110A (en)
PH (1) PH31258A (en)
PL (1) PL175518B1 (en)
PT (1) PT706395E (en)
RU (1) RU2152215C1 (en)
SA (1) SA94150010B1 (en)
SE (1) SE9302218D0 (en)
SG (1) SG49078A1 (en)
SK (1) SK280111B6 (en)
TW (1) TW285640B (en)
WO (1) WO1995000148A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (en) * 1993-06-28 1993-06-28 Ab Astra NEW USE
US5945435A (en) * 1997-07-21 1999-08-31 Darwin Discovery Limited Levobupivacaine and its use
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
EP2209450A4 (en) 2007-11-07 2013-09-25 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
CA2871821C (en) * 2012-05-10 2021-01-12 Painreform Ltd. Depot formulations of a local anesthetic and methods for preparation thereof
SG11201407323WA (en) * 2012-05-10 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of local pain
KR20160081989A (en) 2013-02-28 2016-07-08 더미라, 인코포레이티드 Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151110B1 (en) * 1983-08-01 1989-03-01 Astra Läkemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE9302218D0 (en) * 1993-06-28 1993-06-28 Ab Astra NEW USE

Similar Documents

Publication Publication Date Title
CA2025078A1 (en) External Analgesic lotion and Method of Making
EP0754453B1 (en) Local anesthetics for topical treatment of headache
DE69634609D1 (en) ANALYTIC SYNERGY BY SIMULTANEOUS ADMINISTRATION OF SUBAN-OIL CANS OF A MU-OPIOIDANAGONIST AND A KAPPA-2-OPIOIDANAGONIST
RU93057724A (en) PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PREPARATION AND METHOD OF TREATMENT
ATE423560T1 (en) TRANSDERMAL DOSAGE FORM CONTAINING AN ACTIVE INGREDIENT AND AN ANTAGONIST IN FREE BASE AND IN SALT FORM
EP0352025A3 (en) Use of nalmefene in the treatment of allergic rhinitis
CA2029065A1 (en) Method of treating anxiety related disorders using sertraline
RU96101169A (en) APPLICATION OF ROPIVACAIN IN THE PRODUCTION OF THE PHARMACEUTICAL PRODUCT WITH ANALGESIC ACTION WITH MINIMUM MOTOR BLOCK
ATE179888T1 (en) OPHTHALMIC PREPARATION FOR THE TREATMENT OR PREVENTION OF DRY EYE AND DISEASES CAUSED THEREFROM, CONTAINING 12-SULFODEHYDROABIC ACID
RU94002133A (en) 6-CHLOR-5-FTOR-3- (2-TENOIL) -2-OXINDOL-1-CARBOXAMIDE AS AN ANALOGESIC AND ANIMATERATIVE MEDICATION
RU2002121546A (en) SUBSTANCES FOR THE TREATMENT OF PSORIASIS
WO2004105690A3 (en) Treatment of chronic pain associated with drug or radiation therapy
RU94045866A (en) Use of bis-phenylalkylpiperazines for treatment of disorders caused by substance abuse, method of treatment
RU2004136311A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SEVERINE, CONTAINING 4-HYDROXY-5-MET OXY-4- [2-METHYL-3- (3-METHYL-2-BUTENYL) -2-OXYRANIL] -1-OXASPIRO [2,5] OCTAN- 6-OH
RU95120819A (en) EXTERNAL MEANS AND METHOD OF TREATMENT OF NEUROLOGICAL DISEASES AND DISEASES OF THE MOTOR-MOTOR APPARATUS WITH PAIN SYNDROME AND Puffiness
BR9406865A (en) Use of a pharmaceutically acceptable salt of ropivacaine in the manufacture of a pharmaceutical process for the treatment of a person in need of pain relief and pharmaceutical preparation
RU97104062A (en) APPLICATION OF SELEGYLIN FOR TREATMENT OF EPILEPTIC DISEASES
RU95113855A (en) METHOD FOR CONSERVATIVE TREATMENT OF EYE BURNS
US4575506A (en) Method of treatment for inhibiting the tolerance onset while treating painful syndromes with central analgesics
ATE247965T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PARACETAMOL AND BUSPIRONE HAVING ANALGESIC EFFECT
RU93016030A (en) A MEDICINE STIMULATING THE GRANULOSITARY GROWTH OF HEMATOPHONYA IN CYTOSTATIC MYELODEPRESSIONS
DE345883T1 (en) USE OF DAPIPRAZOLE FOR PRODUCING A MEDICINAL PRODUCT TO PREVENT TOLERANCE DEVELOPMENT IN ANALGETIC TREATMENT WITH MORPHINE.
RU97112901A (en) THROMBOLYTIC PRODUCTS
CA2039643C (en) Anti-wart composition
KR927003530A (en) Use of local anesthetics in the manufacture of pharmaceutical formulations for iontophoresis